OP-92 Bioresorbable Vascular Scaffold System for the Treatment of Coronary Chronic Total Occlusions: a Single Center Experience




Objectives


Bioresorbable vascular scaffold system (BVS) is the latest, fully absorbable vascular therapy system which is used to treat coronary artery disease. BVS has been used in different coronary lesion subsets like acute thrombotic lesions, bifurcation lesions, ostial lesions and lesions originated from bypass grafts. However data about the use of BVS in chronic total occlusions (CTO) is limited and reported as single cases in the literature. We aim to report our BVS experience for the treatment of CTOs in terms of procedural features and 6 months clinical follow up results.




Methods


22 consecutive patients with CTO lesion who have referred to our clinic between January 2013 and May 2014 were analysed. Total number of 28 BVS had implanted. Patient characteristics, procedural features (target vessel, BVS diameter, BVS length, postdilatation rate, type of post dilatation balloon, procedure time, fluoroscopy time, contrast volume, post procedure reference vessel diameter (RVD), post procedure minimal lesion diameter (MLD), type of CTO technique and rate of microcathater use) and 6 months clinical follow up results( death, myocardial infarction, angina, coronary artery bypass graft (CABG), target lesion revascularisation (TLR) and target vessel revascularisation (TVR)) were analysed. Descriptive and frequency statistics was used for statistical analysis.




Methods


22 consecutive patients with CTO lesion who have referred to our clinic between January 2013 and May 2014 were analysed. Total number of 28 BVS had implanted. Patient characteristics, procedural features (target vessel, BVS diameter, BVS length, postdilatation rate, type of post dilatation balloon, procedure time, fluoroscopy time, contrast volume, post procedure reference vessel diameter (RVD), post procedure minimal lesion diameter (MLD), type of CTO technique and rate of microcathater use) and 6 months clinical follow up results( death, myocardial infarction, angina, coronary artery bypass graft (CABG), target lesion revascularisation (TLR) and target vessel revascularisation (TVR)) were analysed. Descriptive and frequency statistics was used for statistical analysis.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-92 Bioresorbable Vascular Scaffold System for the Treatment of Coronary Chronic Total Occlusions: a Single Center Experience

Full access? Get Clinical Tree

Get Clinical Tree app for offline access